Sanofi announced the appointment of Muzammil “Muz” Mansuri as a new member of the Executive Committee, effective February 22, 2016. Mansuri joins Sanofi from Gilead Sciences and will take the position of executive vice president, strategy & business development.
Mansuri will be responsible for all Group strategic planning, business development, strategic intelligence, alliance management and the Sanofi Genzyme Bio Ventures fund.
“Muz brings a wealth of experience as a senior executive within the global biopharmaceutical industry,” said Olivier Brandicourt, CEO, Sanofi. “Muz’s deep understanding of business development and strategy of global biopharmaceutical organisations will allow him to contribute significantly to the overall Group strategy and make him a valuable addition to Sanofi and the Executive Committee.”
A dual citizen of the US and United Kingdom, Mansuri has more than 35 years of experience beginning in 1981 with Shell Research Limited where he began as a research scientist. After Shell, he spent several years with Bristol-Myers Company in various R&D roles with increasing responsibility. From 2007 to 2010, Mansuri was chairman and CEO at CGI Pharmaceuticals. Mansuri’s most recently was senior vice president, research & development strategy and corporate development at Gilead Sciences.
Mansuri holds a bachelor of science degree in chemistry and a Ph.D in organic chemistry from the University College London. He held post-doctoral positions at the University of California, Los Angeles (UCLA) and Columbia University.
The deal will see Microsoft use its capabilities in computational services, cloud computing and artificial intelligence to support drug discovery and development at UCB.
The planned closures come as GSK has agreed to sell its cephalosporins antibiotics business to Sandoz, a division of Swiss pharma firm Novartis, for as much as US$500m.
“The launch of these new formulations provides the nutritional market with much-needed alternative coating systems that address clean label consumer preferences and are easy to implement,” says Kelly Boyer, vice president film coatings at Colorcon.